Hepatobiliary| Volume 158, ISSUE 2, P349-359, August 2015

Transplantation of human stem cell-derived hepatocytes in an animal model of acute liver failure


      Hepatocyte cell transplantation can be life-saving in patients with acute liver failure (ALF); however, primary human hepatocyte transplantation is limited by the scarcity of donor hepatocytes. We investigated the effect of stem cell-derived, hepatocyte-like cells in an animal xenotransplant model of ALF.


      Intraperitoneal d-galactosamine was used to develop a lethal model of ALF in the rat. Human induced pluripotent stem cells (iPSC), human mesenchymal stem cells, and human iPSC combined with human endothelial cells (iPSC + EC) were differentiated into hepatocyte-like cells and transplanted into the spleens of athymic nude rats with ALF.


      A reproducible lethal model of ALF was achieved with nearly 90% death within 3 days. Compared with negative controls, rats transplanted with stem cell-derived, hepatocyte-like cells were associated with increased survival. Human albumin was detected in the rat serum 3 days after transplantation in more than one-half the animals transplanted with hepatocyte-like cells. Only animals transplanted with iPSC + EC-derived hepatocytes had serum human albumin at 14 days posttransplant. Transplanted hepatocyte-like cells homed to the injured rat liver, whereas the ECs were only detected in the spleen.


      Transplantation of stem cell-derived, hepatocyte-like cells improved survival with evidence of in vivo human albumin production. Combining ECs may prolong cell function after transplantation.
      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to Surgery
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Fisher R.A.
        • Strom S.C.
        Human hepatocyte transplantation: worldwide results.
        Transplantation. 2006; 82: 441-449
        • Hughes R.D.
        • Mitry R.R.
        • Dhawan A.
        Current status of hepatocyte transplantation.
        Transplantation. 2012; 93: 342-347
        • Schwartz R.E.
        • Reyes M.
        • Koodie L.
        • Jiang Y.
        • Blackstad M.
        • Lund T.
        • et al.
        Multipotent adult progenitor cells from bone marrow differentiate into functional hepatocyte-like cells.
        J Clin Invest. 2002; 109: 1291-1302
        • Hannan N.R.
        • Segeritz C.P.
        • Touboul T.
        • Vallier L.
        Production of hepatocyte-like cells from human pluripotent stem cells.
        Nat Protoc. 2013; 8: 430-437
        • Aoi T.
        • Yae K.
        • Nakagawa M.
        • Ichisaka T.
        • Okita K.
        • Takahashi K.
        • et al.
        Generation of pluripotent stem cells from adult mouse liver and stomach cells.
        Science. 2008; 321: 699-702
        • Le Blanc K.
        • Tammik C.
        • Rosendahl K.
        • Zetterberg E.
        • Ringden O.
        HLA expression and immunologic properties of differentiated and undifferentiated mesenchymal stem cells.
        Exp Hematol. 2003; 31: 890-896
        • Pettinato G.
        • Wen X.
        • Zhang N.
        Formation of well-defined embryoid bodies from dissociated human induced pluripotent stem cells using microfabricated cell-repellent microwell arrays.
        Sci Rep. 2014; 4: 7402
        • Brulport M.
        • Schormann W.
        • Bauer A.
        • Hermes M.
        • Elsner C.
        • Hammersen F.J.
        • et al.
        Fate of extrahepatic human stem and precursor cells after transplantation into mouse livers.
        Hepatology. 2007; 46: 861-870
        • Cauli O.
        • Rodrigo R.
        • Boix J.
        • Piedrafita B.
        • Agusti A.
        • Felipo V.
        Acute liver failure-induced death of rats is delayed or prevented by blocking NMDA receptors in brain.
        Am J Physiol Gastrointest Liver Physiol. 2008; 295: G503-G511
        • Puppi J.
        • Strom S.C.
        • Hughes R.D.
        • Bansal S.
        • Castell J.
        • Dagher I.
        • et al.
        Improving the techniques for human hepatocyte transplantation: report from a consensus meeting in London.
        Cell Transplant. 2012; 21: 1-10
        • Fox I.J.
        • Chowdhury J.R.
        Hepatocyte transplantation.
        Am J Transplant. 2004; 4: 7-13
        • Li A.P.
        Human hepatocytes: isolation, cryopreservation and applications in drug development.
        Chem Biol Interact. 2007; 168: 16-29
        • Baiguera S.
        • Jungebluth P.
        • Mazzanti B.
        • Macchiarini P.
        Mesenchymal stromal cells for tissue-engineered tissue and organ replacements.
        Transpl Int. 2012; 25: 369-382
        • Snykers S.
        • De Kock J.
        • Rogiers V.
        • Vanhaecke T.
        In vitro differentiation of embryonic and adult stem cells into hepatocytes: state of the art.
        Stem Cells. 2009; 27: 577
        • Shi L.L.
        • Liu F.P.
        • Wang D.W.
        Transplantation of human umbilical cord blood mesenchymal stem cells improves survival rates in a rat model of acute hepatic necrosis.
        Am J Med Sci. 2011; 342: 212-217
        • Krampera M.
        • Glennie S.
        • Dyson J.
        • Scott D.
        • Laylor R.
        • Simpson E.
        • et al.
        Bone marrow mesenchymal stem cells inhibit the response of naive and memory antigen-specific T cells to their cognate peptide.
        Blood. 2003; 101: 3722-3729
        • Kern S.
        • Eichler H.
        • Stoeve J.
        • Kluter H.
        • Bieback K.
        Comparative analysis of mesenchymal stem cells from bone marrow, umbilical cord blood, or adipose tissue.
        Stem Cells. 2006; 24: 1294-1301
        • Aasen T.
        • Raya A.
        • Barrero M.J.
        • Garreta E.
        • Consiglio A.
        • Gonzalez F.
        • et al.
        Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes.
        Nat Biotechnol. 2008; 26: 1276-1284
        • Takahashi K.
        • Tanabe K.
        • Ohnuki M.
        • Narita M.
        • Ichisaka T.
        • Tomoda K.
        • et al.
        Induction of pluripotent stem cells from adult human fibroblasts by defined factors.
        Cell. 2007; 131: 861-872
        • Yu J.
        • Vodyanik M.A.
        • Smuga-Otto K.
        • Antosiewicz-Bourget J.
        • Frane J.L.
        • Tian S.
        • et al.
        Induced pluripotent stem cell lines derived from human somatic cells.
        Science. 2007; 318: 1917-1920
        • Stutchfield B.M.
        • Forbes S.J.
        • Wigmore S.J.
        Prospects for stem cell transplantation in the treatment of hepatic disease.
        Liver Transpl. 2010; 16: 827-836
        • Kmiec Z.
        Cooperation of liver cells in health and disease.
        Adv Anat Embryol Cell Biol. 2001; 161 (1–151): III-XIII
        • Han S.
        • Dziedzic N.
        • Gadue P.
        • Keller G.M.
        • Gouon-Evans V.
        An endothelial cell niche induces hepatic specification through dual repression of wnt and notch signaling.
        Stem Cells. 2011; 29: 217-228
        • Ponder K.P.
        • Gupta S.
        • Leland F.
        • Darlington G.
        • Finegold M.
        • DeMayo J.
        • et al.
        Mouse hepatocytes migrate to liver parenchyma and function indefinitely after intrasplenic transplantation.
        Proc Natl Acad Sci U S A. 1991; 88: 1217-1221